Cargando…
Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up
BACKGROUND: Chronic kidney disease is almost always accompanied by anaemia. Erythropoietin-stimulating agents (ESA) can increase haemoglobin concentration and thus reduce the frequency of anaemia-related complications including the cardiovascular events. AIM: The aim of the study was to collect pros...
Autores principales: | Malyszko, Jolanta, Drozdz, Maciej, Zolkiewicz, Agnieszka, Rutkowski, Boleslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905211/ https://www.ncbi.nlm.nih.gov/pubmed/23136027 http://dx.doi.org/10.1007/s11255-012-0303-0 |
Ejemplares similares
-
Low-Volume Home Haemodialysis and In-Centre Haemodialysis: Comparison of Dialysis Adequacy in Obese Individuals
por: Alalwan, Adel A, et al.
Publicado: (2023) -
Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 – A Single Centre Experience
por: Vardhan, Harsh, et al.
Publicado: (2021) -
Biomarkers of iron metabolism in chronic kidney disease
por: Tomasz, Glogowski, et al.
Publicado: (2020) -
Residual Renal Function – How Fast Does the Residual Urine Output Function Decline in the First Year of Haemodialysis? – A Scoping Review
por: Steinwandel, Ulrich, et al.
Publicado: (2022) -
Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant
por: Malyszko, Jolanta, et al.
Publicado: (2017)